Objective To analyse the efficacy and safety of rituximab in the treatment of non-renal systemic
lupus erythematosus (SLE). Methods We systematically searched MEDLINE, EMBASE …

Objective To analyze the efficacy and safety of nonbiologic immunosuppressants in the
treatment of nonrenal systemic lupus erythematosus (SLE). Methods We conducted a sensitive …

Objectives To assess the effects of lifestyle habits on the disease activity and damage, the
occurrence of flares and quality of life of people with systemic lupus erythematosus (SLE). …

… Author links open overlay panel Íñigo Rúa-Figueroa MD a , Javier López-Longo MD b ,
María Galindo-Izquierdo MD c , Jaime Calvo-Alén MD d , Víctor Del Campo MD e , Alejandro …

From the beginning of the COVID-19 pandemic, more than 4.7 million cases have been
detected in the world, Spain being one of the countries hardest hit by the SARS-CoV-2. 1 The …

… Fernández-Nebro, Antonio MD, PhD; Rúa-Figueroa, Íñigo MD, PhD; López-Longo,
Francisco J. MD, PhD; Galindo-Izquierdo, María MD, PhD; Calvo-Alén, Jaime MD, PhD; …

Background/objectives The European League Against Rheumatism (EULAR)/American
College of Rheumatology (ACR) 2019 classification criteria for systemic lupus erythematosus …

Objectives The European League Against Rheumatism (EULAR)/American College of
Rheumatology (ACR) 2019 Classification Criteria for systemic lupus erythematosus (SLE) have …

Systemic lupus erythematosus (SLE) is an autoimmune disease characterized by multiple
organ involvement and pronounced racial and ethnic heterogeneity. The aims of the present …

Objective Relapses and failure are frequent in systemic vasculitis (SV) patients. Biological
agents have been prescribed as rescue therapies. The aim of this systematic review is to …